BackDenali Therapeutics Overview
Denali Therapeutics Inc

Denali Therapeutics Target Price

Where could DNLI trade next? Consensus target price: $32.

Get informed when a big investor buys or sells

+ Follow

Share Price

$23.15

Average Target Price

$32.0038.2% upside

6 analysts in the last 4 months

High: $41 | Low: $23

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-23Morgan Stanley$3655.5% upsideOpen
2026-07-13WedbushLaura Chico$2612.3% upsideOpen
2026-06-22Stifel NicolausPaul Mattels$4177.1% upsideOpen
2026-05-22Morgan Stanley$3551.2% upsideOpen
2026-05-22Deutsche Bank$3133.9% upsideOpen
2026-05-08WedbushLaura Chico$230.6% downsideOpen
2026-03-26Deutsche Bank$3551.2% upsideOpen
2026-03-02JefferiesAndrew Tsai$4072.8% upsideOpen
2026-01-08Morgan StanleySean Laaman$4072.8% upsideOpen
2026-01-07UBSMichael Yee$258% upsideOpen
2025-12-11WedbushLaura Chico$3029.6% upsideOpen
2025-12-05WedbushLaura Chico$3133.9% upsideOpen
2025-11-17Stifel NicolausPaul Mattels$3759.8% upsideOpen
2025-01-07BTIGThomas Shrader$3238.2% upsideOpen
2024-11-01JefferiesMichael Yee$4594.4% upsideOpen
2024-10-14BTIGThomas Shrader$3551.2% upsideOpen
2024-09-04Bank of America SecuritiesTazeen Ahmad$2925.3% upsideOpen
2024-09-03B.Riley FinancialMarank Mamtani$3342.5% upsideOpen
2024-09-03Goldman SachsSalveen Richter$4698.7% upsideOpen
2024-09-03Stifel NicolausPaul Mattels$225% downsideOpen
2021-08-05Goldman SachsSalveen Richter$112383.8% upsideOpen
2021-05-18UBSEsther Rajavelu$70202.4% upsideOpen

Denali Therapeutics (DNLI) FAQ

Denali Therapeutics (DNLI) currently reports a target price of $32. Use the charts on this page to explore Denali Therapeutics's target price history and peer comparisons.

Analysts' average 12-month price target for Denali Therapeutics is $32, about 38.2% upside from the current share price of $23.15. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $32, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Denali Therapeutics, and consider following DNLI for alerts when major investors trade the stock.

Denali Therapeutics is classified in the Healthcare sector. On target price, it currently shows $32. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DNLI with unrelated industries.